BIOMAT Database Logo BIOMAT Database Logo

[Long-term results of amiodarone therapy in patients with sustained ventricular tachycardia or ventricular fibrillation for prevention of cardiac sudden death]. 1994

H Kasanuki, and T Inaba, and S Ohnisi, and M Shoda, and N Matuda, and S Hosoda
Department of Cardiology, Tokyo Women's Medical College, Heart Institute of Japan.

UI MeSH Term Description Entries
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000638 Amiodarone An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance. Amiobeta,Amiodarex,Amiodarona,Amiodarone Hydrochloride,Amiohexal,Aratac,Braxan,Corbionax,Cordarex,Cordarone,Kordaron,L-3428,Ortacrone,Rytmarone,SKF 33134-A,Tachydaron,Trangorex,Hydrochloride, Amiodarone,L 3428,L3428,SKF 33134 A,SKF 33134A
D014693 Ventricular Fibrillation A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST. Fibrillation, Ventricular,Fibrillations, Ventricular,Ventricular Fibrillations

Related Publications

H Kasanuki, and T Inaba, and S Ohnisi, and M Shoda, and N Matuda, and S Hosoda
Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
February 1989, Journal of the American College of Cardiology,
H Kasanuki, and T Inaba, and S Ohnisi, and M Shoda, and N Matuda, and S Hosoda
Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation.
April 1993, The American journal of cardiology,
H Kasanuki, and T Inaba, and S Ohnisi, and M Shoda, and N Matuda, and S Hosoda
Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables.
February 1985, The American journal of cardiology,
H Kasanuki, and T Inaba, and S Ohnisi, and M Shoda, and N Matuda, and S Hosoda
Implantable cardioverter defibrillator for prevention of sudden cardiac death in patients with ventricular tachycardia and ventricular fibrillation: ICD therapy in sudden cardiac death.
March 1993, Pacing and clinical electrophysiology : PACE,
H Kasanuki, and T Inaba, and S Ohnisi, and M Shoda, and N Matuda, and S Hosoda
Flecainide: long-term effects in patients with sustained ventricular tachycardia or ventricular fibrillation.
June 1990, Journal of cardiovascular pharmacology,
H Kasanuki, and T Inaba, and S Ohnisi, and M Shoda, and N Matuda, and S Hosoda
Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
November 1983, The American journal of cardiology,
H Kasanuki, and T Inaba, and S Ohnisi, and M Shoda, and N Matuda, and S Hosoda
Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
June 1984, The American journal of cardiology,
H Kasanuki, and T Inaba, and S Ohnisi, and M Shoda, and N Matuda, and S Hosoda
Can amiodarone prevent sudden cardiac death in patients with hemodynamically tolerated sustained ventricular tachycardia and coronary artery disease?
May 2005, Cardiovascular drugs and therapy,
H Kasanuki, and T Inaba, and S Ohnisi, and M Shoda, and N Matuda, and S Hosoda
Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone.
September 1990, The American journal of cardiology,
H Kasanuki, and T Inaba, and S Ohnisi, and M Shoda, and N Matuda, and S Hosoda
Prediction of Sudden Cardiac Death Manifesting With Documented Ventricular Fibrillation or Pulseless Ventricular Tachycardia.
April 2022, JACC. Clinical electrophysiology,
Copied contents to your clipboard!